Novel Nasal Spray Sentinox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Study results Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Positive Interim Data from Its Clinical Trial of Novel Nasal Spray Sentinox in SARS-CoV-2 Infected Patients 27-Oct-2021 / 07:00 CET/CES.

Giancarlo icardiMichael millerRaghuram ram selvarajuJack weinsteinAdvita lifescience gmbPharma researchGroup news serviceEqs groupSwiss exchangeRx communications groupHolding ag keyTherapeutic wholly owned subsidiaryReports positive interim dataIts clinical trialNovel nasal spray sentinoxSuggest it could be effective